Press releaseACCESS Newswire
Fifty 1 Labs
FITY · Other
$0.0001−$0.0002 (−66.67%)TodayMarket closed ·
Prev close $0.0003
Latest news
- Press releaseACCESS Newswire
Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform
- Press releaseACCESS Newswire
Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth
- Press releaseACCESS Newswire
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health
- Press releaseGlobe Newswire
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
- Press releaseGlobe Newswire
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
- Press releaseGlobe Newswire
Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.
- Press releaseGlobe Newswire
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
- Press releaseGlobe Newswire
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
- Press releaseGlobe Newswire
Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032
- Press releaseGlobe Newswire
UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success
- Press releaseGlobe Newswire
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
- Press releasePRNewswire
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.